Orbimed Advisors LLC Personalis, Inc. Transaction History

Orbimed Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$4.75 - $12.41 $2.3 Million - $6 Million	-483,842 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$14.16 - $25.34 $2.6 Million - $4.66 Million	183,842 Added 61.28%	483,842 $7.1 Million
Q2 2019 Aug 14, 2019	BUY	$27.0 - $30.25 $8.1 Million - $9.08 Million	300,000 New	300,000 $8.15 Million

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $242M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.